Roundtable Discussion:Individualized Cancer Vaccines: Development Strategies for Neoantigen Selection, Clinical Development & Regulatory Approval
Time: 1:30 pm
day: Conference Day Two
Details:
- How to determine the best clinical setting for individualized cancer therapies for the easiest path through the clinic
- What are the different combination therapy strategies with personalized cancer vaccines for positive patient response?
- What is the dosing schedule in trials for personalized cancer vaccines for the most effective patient response?
